Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 10, 2026
MSTY ETF: +15% Gain Over 30 Days as MSTR Rebounds, Yet Down -26% for the Quarter

MSTY ETF: +15% Gain Over 30 Days as MSTR Rebounds, Yet Down -26% for the Quarter

Key Takeaways

  • MSTY gained roughly 15% over the trailing 30 days, climbing from about $12.51 to $14.40 as its underlying, MSTR, rebounded sharply.
  • The fund remains down roughly 26% over the trailing three months, reflecting a steep June drawdown in MSTR that the synthetic covered-call strategy largely mirrored on the downside.
  • MSTY is an actively managed, non-diversified income ETF that sells call options against synthetic exposure to MSTR, capping upside participation while retaining full downside risk.
  • The recent advance was driven primarily by strength in MSTR—closely tied to Bitcoin price action—though the options cap limited MSTY's gain versus the underlying.
  • Weekly income distributions, a portion of which may be classified as return of capital (ROC), remain a defining feature of the fund's total-return profile.

YieldMax MSTR Option Income Strategy ETF (MSTY) Overview and Portfolio Exposure

The YieldMax MSTR Option Income Strategy ETF (MSTY) is an actively managed, non-diversified exchange-traded fund that seeks current income as its primary objective, with a secondary objective of exposure to the share price of MSTR, subject to a limit on potential investment gains. Launched in February 2024, the fund charges a net expense ratio of roughly 0.99% and manages assets in the range of several hundred million to roughly $1 billion depending on market conditions.

Rather than holding a traditional basket of equities, MSTY deploys a synthetic covered-call and synthetic covered-call spread strategy. The portfolio is dominated by short-term U.S. Treasury bills and notes held as collateral, alongside a series of exchange-traded and FLEX call options on MSTR, with only a negligible direct position in the underlying stock. The strategy is engineered to generate option premium income while participating in MSTR's price movements—fully on the downside, but only partially on the upside because sold calls cap the fund's gains. I also checked this using Tickeron’s AI Screener to see how the fund compares to other covered-call vehicles in the space.

MSTY Price Performance: Last 30 Days vs. Quarter

Over the trailing 30 days, MSTY advanced approximately 15%, rising from a closing price near $12.51 to about $14.40. The move was not a steady climb: the fund consolidated through most of the period before a sharp late-August surge, followed by a modest pullback into the most recent sessions.

The broader three-month trend tells a different story. Measured from a closing level near $19.38 at the start of the quarter, MSTY is down roughly 26%. This reflects the asymmetric nature of the strategy—when MSTR declined sharply in June, MSTY captured nearly the full magnitude of that loss, while the subsequent rebound was partially capped by the sold call positions.

What Drove MSTY Price in the Last 30 Days

The primary driver of MSTY's 30-day advance was a powerful rally in MSTR, which climbed roughly 30% over the same window. MSTR—formerly MicroStrategy—operates as a high-beta proxy for Bitcoin because of its position as one of the largest corporate holders of the digital asset. A rebound in Bitcoin prices translated into a sharp re-rating of MSTR shares, which lifted the value of MSTY's synthetic long exposure.

However, MSTY captured only about half of MSTR's gain. Because the fund systematically sells call options against its exposure, gains above the selected strike prices accrue to option buyers rather than to fund shareholders. Option premium income cushioned the fund during volatile stretches, but the cap on participation meant MSTY could not fully track the underlying's move.

What Drove MSTY Performance Over the Last Quarter

The quarter's negative performance is rooted in the June drawdown in MSTR, which fell roughly 40% from its early-June level before finding a floor. MSTY's synthetic structure—particularly the short put leg that replicates long exposure—meant the fund absorbed most of that decline. This is a structural feature of the strategy: downside is uncapped, while upside is deliberately limited.

Compounding the price trend, MSTY distributes income weekly, and a meaningful portion of those distributions can be classified as return of capital. This mechanism tends to reduce the fund's net asset value (NAV) and share price over time, even when the underlying strategy is functioning as designed. The combination of MSTR's volatility, Bitcoin-driven sentiment shifts, and ongoing distributions explains the divergence between the fund's recent 30-day bounce and its negative quarterly price trend. From what I see, these dynamics are worth monitoring closely.

MSTY ETF Outlook: What Investors Should Watch Next

The most important variable for MSTY remains the trajectory of MSTR, which in turn is closely linked to Bitcoin's price. Continued strength in digital assets would support the fund's synthetic long exposure, while renewed weakness would again test its uncapped downside.

Investors should also monitor the mechanics of the options strategy itself: the strike prices and roll cadence of the sold calls determine how much of any underlying rally the fund can capture. On the income side, the sustainability and composition of distributions—specifically the share classified as return of capital versus option premium income—will affect both total return and the fund's NAV over time. Finally, the interest-rate environment influences the yield on the fund's Treasury collateral, and elevated volatility in both MSTR and Bitcoin will continue to drive the premium income that underpins the strategy. These factors, rather than any single day's price action, are likely to shape MSTY's behavior in the months ahead.

Exploring Tickeron’s AI Screener for ETF Analysis

In my research on income-focused ETFs like MSTY, I turned to Tickeron’s AI Screener to quickly compare similar covered-call strategies and volatility metrics across the market. The platform lets me scan thousands of securities with technical indicators, fundamentals, and AI-generated signals, helping surface comparable ideas without manual effort. It has become a useful part of my workflow when evaluating how MSTY stacks up against peers in the options-income space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MSTY

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


MSTY's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for MSTY moved out of overbought territory on August 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 instances where the indicator moved out of the overbought zone. In of the 13 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSTY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MSTY broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 19, 2026. You may want to consider a long position or call options on MSTY as a result. In of 39 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MSTY moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MSTY crossed bullishly above the 50-day moving average on August 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MSTY advanced for three days, in of 143 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 74 cases where MSTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Industry description

The investment seeks current income; the fund’s secondary investment objective is to seek exposure to the share price of the common stock of MicroStrategy Incorporated d/b/a Strategy, subject to a limit on potential investment gains. The fund is an actively managed ETF that seeks current income while maintaining the opportunity for exposure to the share price of the common stock of MicroStrategy Incorporated, subject to a limit on potential investment gains. The fund is non-diversified.
View a ticker or compare two or three
MSTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Derivative Income
Address
United States
Phone
N/A
Web
N/A
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.